WASHINGTON — President Donald Trump’s commission on the opioid crisis called Wednesday for a nationwide system of drug courts and easier access to alternatives to opioids for people in pain, part of a wide-ranging menu of upgrades it said are needed to curb the opioid epidemic.
The commission, headed by New Jersey Gov. Chris Christie (R), called for expanding drug courts – an alternative system that tries to channel substance abusers accused of crimes into treatment – into all 93 federal court jurisdictions.
The 56 recommendations in the report include requiring doctors to show that they have received training in the safe provision of opioids before they can renew with the Drug Enforcement Administration their licenses to handle controlled substances. The panel also wants to —mandate that medical providers check prescription drug monitoring databases to ensure that patients aren’t “doctor-shopping” for such medications. In some states, use of that technology is voluntary.
The American Medical Association has expressed concern that federally mandated “one-size-fits-all” training would conflict with state requirements for education and do little to speed the end of the crisis.
The commission specifically declined to endorse the use of marijuana for pain, despite some studies suggesting that access to marijuana may decrease opioid deaths. Christie said in his cover letter to the president that there is “a lack of sophisticated outcome data on dose, potency and abuse potential for marijuana.”
Nor did the commission endorse establishing safe injection sites where intravenous drug users can inject drugs under the supervision of trained personnel who prevent them from overdosing.
At the commission’s final meeting, at which members approved the report, Christie spoke passionately about ending the stigma surrounding drug addiction. He used the example of his mother, who was addicted to cigarettes for 55 years before she was diagnosed with lung cancer at 71. When that happened, he said, “no one told me she was getting what she deserved. No one told me they weren’t praying for her.”
Like Trump, who declared the opioid crisis a “public health emergency” six days ago, the President’s Commission on Combating Drug Addiction and the Opioid Crisis identified no new funding for the drug crisis, which claims the lives of an estimated 175 people every day. But it called for block grants of substance-abuse aid that would consolidate federal funding from a variety of sources and send it to cities and states that are fighting the battle on their streets.
Trump’s emergency declaration, which the commission had urged along with eight other recommendations in its July interim report, allows the president to direct all federal agencies to speed aid to localities in the grip of what he called “the worst drug crisis in American history.”
Special report: Cannabis & fitness
One important step he signaled was a decision to have the Department of Health and Human Services waive a 1970s-era policy that blocked Medicaid payments to inpatient —facilities with more than 16 beds for treating substance abuse. That should make treatment more widely available. Trump also said the U.S. Postal Service and the Department of Homeland Security are strengthening package inspections in an attempt to reduce the flow of the street drug fentanyl, much of which is synthesized in China, sent to the United States and mixed with powdered heroin by dealers. On Wednesday, the commission recommended stronger penalties for fentanyl trafficking.
Trump suggested that the federal government might file suit against companies he called “bad actors,” presumably those in the pharmaceutical industry that have allowed painkillers to reach the black market. Private attorneys have already filed some lawsuits, and a coalition of 41 state attorneys general is investigating the role of some companies in the epidemic.
But the president was harshly criticized by activists and Democratic lawmakers for failing to put significant new funding into a battle that many say will require tens of billions of dollars, especially for treatment of the 21 million people with substance abuse disorders. Only about 10 percent of them receive treatment of any kind.
Don’t miss our reviews of strains, vape oils and other cannabis products.
Overdoses from prescription drugs have killed 200,000 people since 2000, and more than 500,000 have succumbed to overdoses of all kinds during the same period. Drug deaths are expected to exceed 60,000, a record, when final numbers are available for 2016. As the crisis has evolved, heroin and fentanyl are responsible for an ever larger share of the deaths.
Christie’s commission called for expanding medication-assisted treatment, which many experts have called the most effective approach and which Food and Drug Administration Commissioner Scott Gottlieb has endorsed. That therapy provides users with buprenorphine, methadone and naltrexone in an attempt to wean them off addiction to heroin or prescription narcotics.
The commission also said the government must adjust the way insurance rates are set, saying they currently encourage doctors to use opioid painkillers rather than physical therapy or other treatments that do not involve drugs.
Similarly, it recommended that the Centers for Medicare and Medicaid Services eliminate questions about pain from satisfaction surveys that are used rate hospital performance. Physicians have said they feel pressure to treat pain aggressively, often with drugs, so they are not penalized on such surveys. The start of the opioid epidemic in the early 2000s is widely blamed on overprescribing of opioid medications.
To subscribe to The Cannifornian’s email newsletter, click here.
The post White House opioid commission rejects medical marijuana as pain relief option appeared first on The Cannifornian.